Content about Södertälje Municipality

April 8, 2013
Patients taking AstraZeneca RA drug show partial improvement

An experimental drug developed by AstraZeneca for rheumatoid arthritis produced mixed results in measurements of patients' conditions, according to results of a late-stage clinical trial.

March 25, 2013
Actavis can launch generic version of Crestor in 2016, under deal with AstraZeneca

Generic drug maker Actavis has reached a deal with AstraZeneca that will allow it to launch a version of a drug used to treat cholesterol in three years, Actavis said Monday.

March 22, 2013
AstraZeneca, Moderna Therapeutics to develop drugs using RNA technology

AstraZeneca will pay $420 million to Moderna Therapeutics in a deal to develop drugs for a variety of diseases using a technology developed by Moderna, AstraZeneca said.

August 23, 2012
FDA approves Wockhardt hypertension drug

The Food and Drug Administration has approved a generic drug for high blood pressure made by Wockhardt, the Indian drug maker said.

August 13, 2012
Pfizer will shepherd OTC Nexium through switch process

Pfizer will be the next consumer healthcare company to reach the market with a switched proton-pump inhibitor.

August 9, 2012
Bristol-Myers Squibb, AstraZeneca expand diabetes deal

AstraZeneca paid $3.2 billion to Amylin Pharmaceuticals Thursday following the latter's acquisition by Bristol-Myers Squibb, AstraZeneca and Bristol said.

August 1, 2012
FDA approves Watson asthma generic

The Food and Drug Administration has approved a generic drug designed to treat asthma in children.

June 19, 2012
AstraZeneca, Rigel partner on worldwide license agreement for chronic asthma treatment

AstraZeneca and Rigel Pharmaceuticals have entered an exclusive worldwide license agreement for the global development and commercialization of an investigational treatment for moderate to severe chronic asthma.

May 15, 2012
AstraZeneca CEO David Brennan to step down

The head of drug maker AstraZeneca will retire next month, the company said.

April 23, 2012
AstraZeneca buys Ardea Biosciences for $1.26 billion

Anglo-Swedish drug maker AstraZeneca will buy a San Diego-based biotech company for $1.26 billion, the two said Monday.

April 12, 2012
AstraZeneca launches Dutoprol

AstraZeneca has launched a new drug for treating high blood pressure, the company said Thursday.

March 26, 2012
Court dismisses AstraZeneca case against FDA

A federal court has dismissed a case that drug maker AstraZeneca filed against regulators regarding a drug used to treat psychotic and bipolar disorders, the company said Monday.

February 1, 2012
Impax licenses migraine drug rights from AstraZeneca

Impax Pharmaceuticals said Wednesday that it obtained exclusive U.S. commercial rights to a drug for migraine headaches made by AstraZeneca.

January 19, 2012
Bristol-Myers Squibb, AstraZeneca diabetes drug hits speed bump at FDA

The Food and Drug Administration has declined to approve a drug for Type 2 diabetes made by Bristol-Myers Squibb and AstraZeneca, saying it needs additional clinical data, the companies said Thursday.

November 2, 2011
FDA approves Endo generic Plendil

The Food and Drug Administration has approved a drug made by Endo Pharmaceuticals for high blood pressure.

October 7, 2011
AstraZeneca settles with generic drug makers over Seroquel XR

Anglo-Swedish drug maker AstraZeneca has settled patent infringement lawsuits that it filed against two companies that had sought to market generic versions of one of its drugs.

August 25, 2011
AstraZeneca introduces Rx savings program for Nexium patients

AstraZeneca is offering a discount savings program for its prescription acid reflux disease treatment.

August 22, 2011
AstraZeneca's Brilinta now available

A new drug made by AstraZeneca is available in pharmacies following its regulatory approval in July, the company said Monday.

August 9, 2011
Report: Pfizer, AstraZeneca file patent suits against Hetero

Hetero is at the center of two patent litigation suits for attempting to market generic versions of Viagra and Nexium, according to published reports.

July 21, 2011
Brilinta receives FDA approval

The Food and Drug Administration has approved a drug made by AstraZeneca to reduce the rate of heart attacks in patients with acute coronary syndrome, the Anglo-Swedish drug maker said.

July 20, 2011
FDA committee doesn't recommend regulatory approval for dapagliflozin

A Food and Drug Administration committee of experts has advised against approving a drug for Type 2 diabetes made by AstraZeneca and Bristol-Myers Squibb, the companies said Tuesday.

June 28, 2011
AstraZeneca, BMS say late-stage trial of Onglyza met primary endpoint

A cobranded Type 2 diabetes treatment may help reduce blood-sugar levels among patients when combined with insulin (with or without metformin), according to a late-stage clinical trial.

June 23, 2011
AstraZeneca sells off Astra Tech to Dentsply

AstraZeneca announced that it is selling its Astra Tech business to a professional dental products company in a cash transaction valued at about $1.8 billion.

April 27, 2011
AstraZeneca adds 'click-to-chat' feature to Crestor, Nexium websites

AstraZeneca has launched a new technology on two of its products' websites to give consumers an option to contact a live AstraZeneca customer service representative with just a click of a button.

April 25, 2011
AstraZeneca's thyroid cancer drug launches

Anglo-Swedish drug maker AstraZeneca has made the drug vandetanib available to certain thyroid cancer patients.

© 2013 Drug Store News. All Rights Reserved.